SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-098940
Filing Date
2024-09-11
Accepted
2024-09-11 16:30:08
Documents
1
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423807-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2423807-1_4seq1.xml 4 9460
  Complete submission text file 0001104659-24-098940.txt   11049
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AZRIELI CENTER ROUND TOWER TER AVIV L3 6701101
Business Address
Dunn Gordon (Reporting) CIK: 0001958139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37846 | Film No.: 241292956